Top Markets
#1 DogBull DogBull +25.95%
#2 Merlin's Seal BTC Merlin's Seal BTC +25.80%
#3 Siacoin Siacoin +17.80%
#4 Cash Cat Cash Cat +13.29%
#5 The Bitcoin Bull The Bitcoin Bull +10.51%
#6 Asteroid Shiba Asteroid Shiba +8.70%
#7 0G 0G +8.69%
#8 Akedo Akedo +7.86%
#9 The Black Bull The Black Bull +6.19%
#10 Seeker Seeker +6.12%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Carlsmed, Inc. Carlsmed, Inc.

Carlsmed, Inc.

CARL
Rank in Stocks #14039
Carlsmed, Inc., a commercial-stage medical technology company, designs,... Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Share Price
$16.23
Last synced: 2026-08-31
Market Cap
$441.21M
Change (1 day)
-3.85%
Change (1 year)
22.03%
Country
US
Trade Carlsmed, Inc. (CARL)

Category

Healthcare
P/E ratio for Carlsmed, Inc. (CARL)
P/E ratio as of 2026 TTM: 0
According to Carlsmed, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Carlsmed, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 52.64 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.